Cargando…
Behavioral Effects of Acute Systemic Low-Dose Clozapine in Wild-Type Rats: Implications for the Use of DREADDs in Behavioral Neuroscience
Designer receptors exclusively activated by designer drugs (DREADDs) are popular tools used to manipulate the activity of defined groups of neurons. Recent work has shown that DREADD effects in the brain are most likely not mediated by the proposed ligand clozapine-N-oxide (CNO) but its metabolite c...
Autores principales: | Ilg, Ann-Kathrin, Enkel, Thomas, Bartsch, Dusan, Bähner, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102325/ https://www.ncbi.nlm.nih.gov/pubmed/30154702 http://dx.doi.org/10.3389/fnbeh.2018.00173 |
Ejemplares similares
-
Clozapine N-Oxide Administration Produces Behavioral Effects in Long–Evans Rats: Implications for Designing DREADD Experiments
por: MacLaren, Duncan A. A., et al.
Publicado: (2016) -
The Use of DREADDs to Deconstruct Behavior
por: Whissell, Paul D., et al.
Publicado: (2016) -
The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice
por: Manvich, Daniel F., et al.
Publicado: (2018) -
Eye-Drops for Activation of DREADDs
por: Keenan, William T., et al.
Publicado: (2017) -
Pharmacokinetic and pharmacodynamic actions of clozapine-N-oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice
por: Jendryka, Martin, et al.
Publicado: (2019)